We have also shown that both Ezrin and NHERF1 are downstream of the insulin growth factor 1 receptor (IGR-1R)/PI3K/Akt signaling axis and regulate CRC cell survival in vitro through the modulation of cell survival markers, XIAP, and survivin [37,38,39]. Here, BIRC5 is linked to colorectal carcinoma.